MiniMedTM 780G System ^
Anticipates.
Adjusts.
Corrects.1,2
Automated for an easier* way to stabilise glucose levels1,2,3
^ Components sold separately
*Compared to the MiniMedTM 670G system. Refers to SmartGuardTM feature. Some user interaction required. Indiviual results may very.
Always Read the Instruction for Use. Medtronic's (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up.
GuardianTM Connect System
Connect
the dots
With glucose levels, trends and alerts on your mobile device
MiniMedTM Mobile Apps
Peace of mind
on the go
Stay in the loop with mobile connectivity for you and your loved ones
CareLinkTM System
Taking care of
your data
See the same reports as your doctor - and collaborate on your care
1. Carlson, A.L. et al. 97-P- Safety and glycaemic outcomes of the MiniMed™AHCL System in subjects with T1D. 80th ADA International Conference, June2020, Chicago+E24
2. Collyns, O. et al. 199-OR- Improved glycaemic Outcomes with MiniMed™AHCL Delivery. 80th ADA International Conference, June 2020, Chicago
3. Bergenstal, R. M. et al. Safety of a Hybrid-Closed Loop Insulin Delivery Systemin Patients with Type 1 Diabetes Jama. 2016; 316 (13): 1407 - 1408